Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy (2019)
- Authors:
- Autor USP: ROCHA, VANDERSON GERALDO - FM
- Unidade: FM
- DOI: 10.1182/bloodadvances.2019000627
- Subjects: TRANSPLANTE HOMÓLOGO; LINFÓCITOS T; LEUCEMIA MIELOIDE AGUDA; DOENÇAS DA MEDULA ÓSSEA; DOENÇA ENXERTO-HOSPEDEIRO; FÁRMACOS IMUNOSSUPRESSORES; CONDICIONAMENTO; SOBREVIVÊNCIA LIVRE DE DOENÇA; ESTUDOS RETROSPECTIVOS
- Agências de fomento:
- Financiado pelo ONR
- Health Resources and Services Administration (US Department of Health and Human Services)United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA) [HHSH250201200016C]
- National Institute of Allergy and Infectious Diseases, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [5U24-CA076518]
- National Heart, Lung, and Blood Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U24-CA076518, 5U10HL069294]
- National Cancer Institute, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [5U24-CA076518, 5U10HL069294]
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2019
- Source:
- Título: Blood advances
- ISSN: 2473-9529
- Volume/Número/Paginação/Ano: v. 3, n. 19, p. 2836-2844, 2019
- Status:
- Artigo publicado em periódico de acesso aberto (Gold Open Access)
- Versão do Documento:
- Versão publicada (Published version)
- Acessar versão aberta:
-
ABNT
SOLOMON, Scott R et al. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, v. 3, n. 19, p. 2836-2844, 2019Tradução . . Disponível em: https://doi.org/10.1182/bloodadvances.2019000627. Acesso em: 09 maio 2026. -
APA
Solomon, S. R., Martin, A. S., Shah, N. N., Fatobene, G., Malki, M. M. A., Ballen, K. K., et al. (2019). Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy. Blood advances, 3( 19), 2836-2844. doi:10.1182/bloodadvances.2019000627 -
NLM
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha VG. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2026 maio 09 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627 -
Vancouver
Solomon SR, Martin AS, Shah NN, Fatobene G, Malki MMA, Ballen KK, Bashey A, Bejanyan N, Meade JB, Rocha VG. Myeloablative vs reduced intensity T-cell-replete haploidentical transplantation for hematologic malignancy [Internet]. Blood advances. 2019 ; 3( 19): 2836-2844.[citado 2026 maio 09 ] Available from: https://doi.org/10.1182/bloodadvances.2019000627 - Comparison of characteristics and laboratory tests of COVID-19 hematological patients from France and Brazil during the pre-vaccination period: identification of prognostic profiles for survival
- Outcomes of subsequent neoplasms after umbilical cord blood transplantation in Europe
- Outcomes after Haploidentical Stem Cell Transplantation with Post-Transplantation Cyclophosphamide in Patients with Primary Immunodeficiency Diseases
- A novel mutation in RHAG causing Rh-null phenotype in Colombia. [Editorial]
- Comparative analysis of the variability of the human leukocyte antigen peptide-binding pockets in patients with acute leukaemia
- Cord blood transplantation for adult mature lymphoid neoplasms in Europe and Japan
- Autologous, allogeneic hematopoietic cell transplantation and CAR-T/NK therapy: what is their real importance in PTCL?
- Long-term clinical outcomes in a cohort of patients with solitary plasmacytoma treated in the modern era
- Validation of a formula predictive of peripheral blood stem cell yield and successful collection in healthy allogeneic donors
- Risk factors and outcomes according to age at transplantation with an HLA-identical sibling for sickle cell disease [Carta]
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
Por se tratar de integração com serviço externo, podem existir diferentes versões do trabalho (como preprints ou postprints), que podem diferir da versão publicada.
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
